Stay updated with breaking news from Resented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Disclaimer: This document is the English version of the Japanese document released on May 11, 2023. It was translated into English and presented solely for the... | May 24, 2023
-- Phase 2 results for dazodalibep in Sjögren’s syndrome to be presented on June 1, 11:35-11:45 a.m. CEST and June 3, 9:35-9:45 a.m. CEST -- -- Planned presentations illustrate... | May 23, 2023
– Results from the completed Collaborative Health Research Projects study with McMaster University presented at the American Thoracic Society International Conference – – Data... | May 23, 2023
PTCL Corporate Briefing Session For the Year 2022 Presented By: GCFO Nadeem Khan ... | May 23, 2023
PARIS (dpa-AFX) - Sanofi and Regeneron Pharmaceuticals Inc. (REGN) presented positive Phase 3 results evaluating the investigational use of Dupixent (dupilumab) compared to placebo in adults currently